Literature DB >> 12725326

Studies on the role of some synthetic curcuminoid derivatives in the inhibition of tumour specific angiogenesis.

P V Leyon1, G Kuttan.   

Abstract

In this study, some of the synthetic curcuminoid derivatives are analyzed for their anti-angiogenic activity. Intraperitoneal administration of the compounds tetrahydrocurcumin (THC), salicyl curcumin (SC) and curcuminIII (C-III) reduced the number of tumour directed capillaries induced by injecting B16F-10 melanoma cells on the ventral side of C57BL/6 mice. THC (14.5 +/- 2.5 capillaries) and SC (16 +/- 2.5 capillaries) were more significant (P < 0.001) than C-III (19 +/- 1.8 capillaries) compared to the untreated control (30.8 +/- 2.1 capillaries). Treatment with these curcuminoids reduced the serum NO as well as TNF-alpha levels of the angiogenesis-induced animals. In vitro NO and TNF-alpha production by the activated MOs were reduced in a concentration dependent manner by the treatment of the curcuminoid compounds.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12725326

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN： 0392-9078


  8 in total

Review 1.  Lesson learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogs.

Authors:  Fazlul H Sarkar; Yiwei Li; Zhiwei Wang; Subhash Padhye
Journal:  Curr Pharm Des       Date:  2010-06       Impact factor: 3.116

2.  Design and synthesis of novel iminothiazinylbutadienols and divinylpyrimidinethiones as ARE inducers.

Authors:  Lin Chen; Sadagopan Magesh; Hong Wang; Chung S Yang; Ah-Ng Tony Kong; Longqin Hu
Journal:  Bioorg Med Chem Lett       Date:  2013-12-24       Impact factor: 2.823

3.  Curcumin improves treatment outcome of Takayasu arteritis patients by reducing TNF-α: a randomized placebo-controlled double-blind clinical trial.

Authors:  Nan Shao; Huixin Jia; Yiwen Li; Jingying Li
Journal:  Immunol Res       Date:  2017-08       Impact factor: 2.829

Review 4.  Botanicals for the prevention and treatment of cutaneous melanoma.

Authors:  Deeba N Syed; Hasan Mukhtar
Journal:  Pigment Cell Melanoma Res       Date:  2011-04-12       Impact factor: 4.693

5.  CLEFMA-an anti-proliferative curcuminoid from structure-activity relationship studies on 3,5-bis(benzylidene)-4-piperidones.

Authors:  Pallavi Lagisetty; Prachi Vilekar; Kaustuv Sahoo; Shrikant Anant; Vibhudutta Awasthi
Journal:  Bioorg Med Chem       Date:  2010-06-22       Impact factor: 3.641

Review 6.  Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.

Authors:  Bharat B Aggarwal; Subash C Gupta; Bokyung Sung
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

7.  Pharmacogenomic Characterization and Isobologram Analysis of the Combination of Ascorbic Acid and Curcumin-Two Main Metabolites of Curcuma longa-in Cancer Cells.

Authors:  Edna Ooko; Onat Kadioglu; Henry J Greten; Thomas Efferth
Journal:  Front Pharmacol       Date:  2017-02-02       Impact factor: 5.810

8.  Curcumin intake affects miRNA signature in murine melanoma with mmu-miR-205-5p most significantly altered.

Authors:  Indra N Dahmke; Christina Backes; Jeannette Rudzitis-Auth; Matthias W Laschke; Petra Leidinger; Michael D Menger; Eckart Meese; Ulrich Mahlknecht
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.